Abstract
Abstract
Background
Vaccine hesitancy poses a global challenge and is acknowledged to be a complex, multifactorial phenomenon. Of particular concern is hesitancy among health professionals, as this may also impact their advocacy roles. There is a lack of theory-based investigations of pharmacy professionals.
Aim
The study aims to determine the behaviour and associated determinants influencing pharmacy professionals’ attitude towards vaccine acceptance and advocacy.
Methods
A cross-sectional survey of 2400 pharmacists and pharmacy technicians at government, semi-government, and private community pharmacies in Qatar. Questionnaire items captured perspectives on COVID vaccine acceptance, advocacy and associated determinants based on the domains and constructs of the Theoretical Domains Framework (TDF). Data were analysed by descriptive and inferential statistics, with TDF items subjected to principal components analysis (PCA).
Findings
The response rate was 38.6% (927/2400). Almost all (n = 825, 89.0%) were willing to receive the vaccine, which was higher for males (p < 0.001) and those in polyclinics (p < 0.05). PCA of acceptance items gave five components, with response to ‘emotions’ being most negative, associated with acceptance (p < 0.001) and more negative in females (p < 0.001). The majority (n = 799, 86.2%) agreed that it was their professional duty to advocate vaccines. PCA for advocacy items gave two components, with the most negative responses for ‘professional role and identity’, which were more negative for those working in hospitals (p < 0.05).
Conclusion
Respondents were least positive regarding emotion-related behavioral determinants for acceptance and professional role and identity for advocacy. Behavior change technique interventions that target these issues have the potential to influence the vaccine hesitancy of pharmacy professionals and other individuals.
Funder
Hamad Medical Corporation
Reference53 articles.
1. Akande OW, Akande TM. COVID-19 pandemic: a global health burden. Niger Postgrad Med J. 2020;27(3):147.
2. Miller IF, Becker AD, Grenfell BT, Metcalf CJE. Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020;26(8):1212–7.
3. Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L. Economic burden of COVID-19: a systematic review. CEOR. 2022;14:293.
4. Worldometer and Coronavirus cases. Reported Cases and Deaths. Worldometer; 2023 https://www.worldometers.info/coronavirus/. Accessed 04 Jan 2023.
5. Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817.